events
Mark your calendar for November 19-21 and meet us at Fi Europe 2024, Messe Frankfurt, Germany. We look forward to connecting with you at this exciting event!
Learn More >>
Products

Enzymes for Research, Diagnostic and Industrial Use

Products
Online Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

24 hour
Promise

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

Adriamycin (Doxorubicin)

Cat No.
CEI-0290
Description
Adriamycin (Doxorubicin) is a inhibitor of DNA topoisomerase II.
CAS No.
25316-40-9
Molecular Weight
579.98
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
topoisomerase II
Molecular Formula
C27H29NO11.HCl
Chemical Name
(8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
Solubility
DMSO 116 mg/mL Water 116 mg/mL Ethanol
In vitro
Doxorubicin (DOX) is an anti-tumour agent. Adniamycin inhibits both cellular DNA and RNA synthesis. Doxorubicin can inhibit MCF-7 and MDA-MB231 with IC50 of 1 uM and 2 uM.
In vivo
Doxorubicin can treat non-Hodgkins lymphoma, multiple myeloma, acute leukemias, Kaposi sarcoma, Ewing sarcoma, Wilm tumor, and cancers of the breast, adrenal cortex, endometrium, lung, ovary, and other sites. It is sometimes used to treat non-cancerous conditions as well.

Our Products Cannot Be Used As Medicines Directly For Personal Use.

0
Click unfold / close
Inquiry Basket
Delete selected Quote Check Out
Decide to move out of the shopping cart?
Sure No, Back

Please choose product!

< Go Back
You have already added to buy this product